应用
选项
-
CD40 Mouse mAb关联靶标: CD40简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody; in vitro CD40 stimulation, Functional assays, Flow; Unconjugated种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: G28.5 偶联: Unconjugated
-
I-A/I-E Rat mAb简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody; in vivo MHC II blockade, Functional assays, ICC, IF, WB, IP, Flow; Unconjugated种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: Unconjugated
-
I-A/I-E Rat mAb (Biotin)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (Biotin); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: Biotin
-
I-A/I-E Rat mAb (FITC)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (FITC); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: FITC
-
I-A/I-E Rat mAb (APC)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (APC); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: Unconjugated
-
I-A/I-E Rat mAb (AF647)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (AF647); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: AF647
-
I-A/I-E Rat mAb (PE)简短描述: mAb (M5/114); Rat anti Mouse I-A/I-E Antibody (PE); Flow种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: M5/114 偶联: PE
-
CD40 Mouse mAb关联靶标: CD40简短描述: CD40 小鼠单克隆种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: G28.5 偶联: Unconjugated
-
CD40 Mouse mAb (Biotin)关联靶标: CD40简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (Biotin); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: G28.5 偶联: Biotin
-
CD40 Mouse mAb (AF647)关联靶标: CD40简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (AF647); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: G28.5 偶联: AF647
-
CD40 Mouse mAb (PE-Cy5)关联靶标: CD40简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (PE-Cy5); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: G28.5 偶联: PE-Cy5
-
CD40 Mouse mAb (FITC)关联靶标: CD40简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (FITC); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: G28.5 偶联: FITC
首页
400-620-6333











